HAYWARD,
Calif., Oct. 26, 2023 /PRNewswire/ -- AcelRx
Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty
pharmaceutical company focused on the development and
commercialization of innovative therapies for use in medically
supervised settings, today announced that it will release third
quarter 2023 financial results after market close on Wednesday, November 8, 2023, then host a live
webcast and conference call at 4:30 p.m.
Eastern Standard Time/1:30 p.m.
Pacific Standard Time to discuss the results and provide an
update on the Company's business.
Webcast Information
The webcast can be accessed here or by visiting the Investors
section of the Company's website at www.acelrx.com and clicking on
the webcast link within Investors/News & Events/Upcoming Events
section. The webcast will include a slide presentation and a replay
will be available on the AcelRx website for 90 days following the
event.
Conference Call Information
Investors who wish to participate in the conference call may do
so by dialing 1-866-361-2335 for domestic callers,
1-855-669-9657 for Canadian callers, or 1-412-902-4204 (toll
applies) for international callers. The conference ID is
10182244.
About AcelRx Pharmaceuticals, Inc.
AcelRx
Pharmaceuticals, Inc. is a specialty pharmaceutical company focused
on the development and commercialization of innovative therapies
for use in medically supervised settings. AcelRx's lead product
candidate, Niyad™ is a lyophilized formulation of nafamostat and is
currently being studied under an investigational device exemption,
or IDE, as an anticoagulant for the extracorporeal circuit, and has
received Breakthrough Device Designation status from the FDA.
AcelRx is also developing two pre-filled syringes in-licensed from
its partner Aguettant: Fedsyra™, a pre-filled ephedrine syringe,
and PFS-02, a pre-filled phenylephrine syringe. This release is
intended for investors only. For additional information about
AcelRx, please visit www.acelrx.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/acelrx-to-host-third-quarter-2023-financial-results-call-and-webcast-on-november-8-2023-301969382.html
SOURCE AcelRx Pharmaceuticals, Inc.